Congress Shields Bayer from Cancer Lawsuits with Glyphosate Provision

Congressional Provision to Shield Bayer

• 🏛️ A provision in a congressional spending bill (Section 453 of HR 4754) aims to shield Bayer, the manufacturer of Roundup and glyphosate, from cancer lawsuits.
• 🚫 This measure would effectively ban future litigation by aligning pesticide labeling exclusively with EPA determinations, even though the EPA does not classify glyphosate as a carcinogen.

Bayer's Legal and Historical Context

• 💰 Bayer, which acquired Monsanto, has already paid approximately $11 billion in settlements to about 100,000 people who claimed Roundup caused cancer.
• ⚖️ Currently, 63,000 lawsuits are pending against Bayer, primarily alleging that Roundup's label failed to warn about potential cancer risks, citing a 2015 International Agency for Research study.
• 📜 Bayer is seeking a Supreme Court ruling on whether a lack of cancer warning on the label constitutes misbranding under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA).
• 🤝 The proposed congressional language follows intense lobbying efforts by Bayer.

Criticism of Corporate and Government Actions

• ⚠️ Critics argue that this provision is an attempt to prevent the government from protecting citizens from a company that is allegedly poisoning them.
• 🧐 Bayer spokesperson Brian Lee claims Section 453 is routine business, while Representative Mike Sinson downplayed it as clarifying existing law to prevent a patchwork of state labeling requirements.
• 🔍 The language could tie the EPA's hands, preventing immediate public label warnings even if new research emerges about pesticide dangers, and could affect over 57,000 other active pesticide ingredients.
• 🏭 Bayer's historical ties to IG Farben, the Nazi-era chemical manufacturer that produced gas for death camps, are highlighted as a point of concern.

Bayer's Motivation and Alternatives

• 📈 Bayer is reportedly desperate to put glyphosate lawsuits behind it, with the company making significant profits from the product.
• 🛑 Anti-pesticide groups are raising alarms, suggesting Bayer should stop producing glyphosate or develop alternatives rather than seeking congressional immunity.
• 💸 The $11 billion in lawsuits is framed as merely the "price of doing business" for a company of Bayer's financial scale.